SCHEMBL29426362

SCHEMBL29426362

CC(C)[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDCD1LG2 Q9BQ51 1/20 0.45
▸ CD274 Q9NZQ7 1/20 0.45
▸ ECE1 P42892 4/20 0.44
▸ BACE1 P56817 2/20 0.41
▸ CTSD P07339 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MME P08473 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ DPP8 Q6V1X1 1/20 0.39
▸ DPP9 Q86TI2 1/20 0.39
▸ PLA2G2A P14555 1/20 0.38
▸ PLA2G5 P39877 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ERAP2 Q6P179 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531923 1.00 PDCD1LG2 (0.45) PDCD1LG2CD274ECE1BACE1CTSD
Hydrochloric Acid SCHEMBL23404120 0.98 PDCD1LG2 (0.44) PDCD1LG2CD274ECE1BACE1CTSD
Hydrochloric Acid SCHEMBL23404112 0.98 PDCD1LG2 (0.44) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL30737597 0.97 BACE1 (0.44) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL29697048 0.92 CD274 (0.49) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL31720964 0.89 ENPEP (0.44) CTSDALDH1A1
SCHEMBL31129130 0.89 PDCD1LG2 (0.47) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL30390006 0.89 CD274 (0.52) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL8528144 0.88 CD274 (0.57) PDCD1LG2CD274ECE1BACE1CTSD
SCHEMBL29572257 0.88 CD274 (0.57) PDCD1LG2CD274ECE1BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12613237-B2 Biosensors for detecting arrestin signaling MONTANA MOLECULAR, LLC (US) 2026-04-28 — — US claimed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 — — WO claimed
WO-2024132726-A1 SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE UNIWERSYTET GDANSKI (PL) 2024-06-27 — — WO claimed
EP-4271387-A1 NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCS CONTAINING AND USE THEREOF Immunext, Inc. (US) 2023-11-08 — — EP claimed
WO-2022150637-A1 NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF IMMUNEXT, INC. (US) 2022-07-14 — — WO claimed
CN-108040482-B Composition for colon cleansing and treatment of gastrointestinal disorders 硬木药品公司 2022-03-29 — — CN claimed
US-12613237-B2 Biosensors for detecting arrestin signaling MONTANA MOLECULAR, LLC (US) 2026-04-28 — — US disclosed
US-20260076944-A1 COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH UNIV CALIFORNIA (US) 2026-03-19 — — US disclosed
EP-4695413-A1 PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF Ohio State Innovation Foundation (US) 2026-02-18 — — EP disclosed
CN-119033924-B Development and application of porcine infectious pleuropneumonia subunit vaccine 吉林大学 2025-04-11 — — CN disclosed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 — — WO disclosed
CN-119432787-A 7 Beta hydroxysteroid dehydrogenase mutant and application thereof in preparation of UDCA 湖北共同甾体药物研究院有限公司 2025-02-14 — — CN disclosed
CN-119286735-A Strain for producing inulin candy transferase and application thereof 齐鲁工业大学(山东省科学院) 2025-01-10 — — CN disclosed
EP-4136118-A1 ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF Immunext, Inc. (US) 2023-02-22 — — EP disclosed
CN-114366819-B Placenta focus specific drug distribution delivery system and preparation method and application thereof 中山大学附属第一医院 2023-01-31 — — CN disclosed
US-11524979-B2 Macrocyclic polypeptides UNIVERSITY OF WASHINGTON (US) 2022-12-13 — — US disclosed
US-20220259265-A1 Inhibitors and Use Thereof in Cancer Treatment THE UNIVERSITY OF SYDNEY (AU) 2022-08-18 — — US disclosed
US-20220168516-A1 PRODUCT DELIVERY DEVICES AND METHODS BREATHE RESTORE, INC. 2022-06-02 — — US disclosed
CN-114366819-A Placenta focus specific drug distribution delivery system and preparation method and application thereof 中山大学附属第一医院 2022-04-19 — — CN disclosed
US-20220102000-A1 PREDICTING BLOOD METABOLITES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2022-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260076944-A1 COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH IDO1, INMT, IDO2 PDCD1LG2 3920/4885CD274 3828/4885ECE1 4695/4885
US-12613237-B2 Biosensors for detecting arrestin signaling ARRB1, RGS19, GPR55 PDCD1LG2 696/4885CD274 1987/4885ECE1 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback